Meredith C. Henderson, PhD, Head, R&D, Provista Diagnostics, describes the dtectDx Breast test.
Meredith C. Henderson, PhD, Head, R&D, Provista Diagnostics, describes the dtectDxBreast test.
DtectDxBreast is essentially a blood test for the detection of breast cancer and is meant to be used in conjunction with mammography. With this test, Henderson says, information is available for a physician to make a decision regarding further imaging or biopsying.
DtectDxBreast is especially beneficial for women under 50 years, who tend to be underserved by mammography. The test is also beneficial, Henderson says, as it should not be affected by dense breast tissue or previous biopsy. If imaging is difficult or confounding in a patient, an empirical value from the dtectDxBreast test is still possible.
Clinical Pearls
Batalini Explores Role of UGT1A1 in Patients Treated With Sacituzumab Govitecan for HR+ MBC
April 22nd 2024During a Community Case Forum live event in partnership with The Arizona Clinical Oncology Society, Felipe Batalini, MD, discussed the TROPiCS-02 trial of sacituzumab govitecan and the impact of the UGT1A1 status on adverse event frequency.
Read More